🔎 Trials Near Me

홈 › 유방암 › 펜실베이니아

펜실베이니아의 유방암 임상 시험

유방암 관련 연구 91개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.

펜실베이니아의 도시

공식 연구 텍스트(영어)

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

  • St. Luke's University Health Network, Bethlehem
  • Penn State Milton S. Hershey Medical Center, Hershey
  • Guthrie Medical Group, Sayre
피험자 모집 중1상
18세 ~ 55세 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07310420

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Penn State Milton S Hershey Medical Center, Hershey
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03418961

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

  • Research Facility, Philadelphia
  • Research Facility, Pittsburgh
피험자 모집 중1/2상
전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06590857

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

  • Abramson Cancer Center, Philadelphia
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT05964504

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Penn State Milton S. Hershey Medical Center, Hershey
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Allegheny (AHN), Pittsburgh
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07214532

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • University of Pennsylvania, Philadelphia
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT05315700

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • St. Luke's University Health Network, Bethlehem
  • Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
  • University of Pennsylvania Hospital, Philadelphia
  • 외 3개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

E-Mindfulness Approaches for Living After Breast Cancer

  • Carlisle Regional Cancer Center, Carlisle
  • WellSpan Medical Oncology and Hematology, Chambersburg
  • Geisinger Medical Center, Danville
  • 외 28개
피험자 모집 중3상
18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Geisinger Medical Center, Danville
  • 외 7개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • USOR Alliance Cancer Specialist, Doylestown
  • Allegheny Health Network, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • WellSpan Medical Oncology and Hematology, Chambersburg
  • 외 13개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • University of Pennsylvania, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

  • University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07114601

Distance-Based Exercise to Preserve Function and Prevent Disability

  • UPMC Hillman Cancer Center at Butler Health System, Butler
  • UPMC Hillman Cancer Center - Passavant - Cranberry, Cranberry Township
  • IRMC Cancer Center, Indiana
  • 외 6개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07059884

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Lehigh Valley Hospital-Cedar Crest, Allentown
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem
  • Bryn Mawr Hospital, Bryn Mawr
  • 외 57개
피험자 모집 중3상
18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

  • University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058), Pittsburgh
  • Cancer Care Associates Of York ( Site 0063), York
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07060807

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

  • Penn Medicine - Lancaster General Hospital, Lancaster
  • Capital Health Hematology Oncology Specialists, Newton
  • Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
  • 외 2개
피험자 모집 중3상
60세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT06377852

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

  • University of Pittsburgh Medical Center, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07524322

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

  • Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
  • UPMC, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT06774963

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

  • Penn State Health Medical Group - Andrews Patel, Harrisburg
  • Penn State Cancer Institute, Hershey
  • UPMC Magee - Womens Hospital, Pittsburgh
  • 외 1개
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06401421

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

  • Penn State Health Milton S. Hershey Medical Center, Hershey
  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
  • UPMC - Hillman Cancer Center, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07100106

The Cancer of the Pancreas Screening-5 CAPS5)Study

  • University of Pennsylvania, Philadelphia
  • University of Pittsburgh, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 22. 업데이트됨 · NCT02000089

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

  • Fox Chase Cancer Center, Philadelphia
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 10. 14. 업데이트됨 · NCT07140172

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

  • Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06312176

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Pittsburgh
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT05123482

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

  • UPMC Hillman Cancer Center, Pittsburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT06757634

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

  • Lehigh Valley Health Network (Data Collection Only), Allentown
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05534438

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia
  • University of Pittsburgh Medical Center, Pittsburgh
  • WellSpan York Cancer Center, York
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

  • Alliance Cancer Specialists, Horsham
  • University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia
  • University of Pittsburgh (UPMC), Pittsburgh
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06369285

Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

  • Allegheny General Hospital, Pittsburgh
피험자 모집 중관찰 연구
20세 ~ 89세 · 여성 · 2026. 9. 30. 업데이트됨 · NCT07023887

A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer

  • AHN Allegheny General Hospital, Pittsburgh
  • Allegheny General Hospital, Pittsburgh
피험자 모집 중
20세 ~ 89세 · 여성 · 2026. 9. 30. 업데이트됨 · NCT07698314

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Pittsburgh
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Study of AVZO-021 in Patients With Advanced Solid Tumors

  • Avenzo Therapeutics Recruiting Site, Philadelphia
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

  • AHN Allegheny General Hospital, Pittsburgh
  • AHN Allegheny General Hospital, Pittsburgh
피험자 모집 중
20세 ~ 89세 · 여성 · 2026. 9. 28. 업데이트됨 · NCT07704476

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
피험자 모집 중
30세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT02945579

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.